Literature DB >> 1299461

Change and status in quality of life in patients with rheumatoid arthritis.

P Bendtsen1, J O Hörnquist.   

Abstract

Current status in quality of life and deterioration retrospectively attributed to the disease by patients with rheumatoid arthritis (RA) were examined. The study group included 169 female and 53 male patients with probable (n = 70), definite (n = 127) and classical RA (n = 25). In a cross-sectional postal survey the participants self-rated their quality of life according to a generic self-assessment package tailored in part for this study. Shortened parallel ratings by significant others were also performed. The impact of RA on quality of life was pervasive. Heaviest intrusion emerged within the physical life sphere and the behavioural and activity domain, followed by the impact on global life satisfaction and habits. Material, psychological and social life domains were less disrupted. In spite of the pervasive discomfort attributed to the illness, quality of life status was mostly rated as being 'rather good' to 'good'. There was a consistent pattern: the better off currently, the less disturbance from the disease perceived. Higher age and longer duration of RA were significantly correlated to a lower status. In addition, individuals still working rated a higher quality of life and less intrusion of the disease. Self-ratings were corroborated by ratings of significant others. While there was an agreement on the level of the negative impact of the disease, the patients rated their current situation more positively than did significant others. The dual assessment of quality of life status and change appears reasonable and informative as regards rheumatoid arthritis.

Entities:  

Mesh:

Year:  1992        PMID: 1299461     DOI: 10.1007/bf00434943

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  26 in total

1.  Rheumatoid arthritis and the measurement properties of the physical ability dimension of the Stanford Health Assessment Questionnaire.

Authors:  M B Ferraz; E Atra
Journal:  Clin Exp Rheumatol       Date:  1989 Jul-Aug       Impact factor: 4.473

2.  Quality of life: concept and assessment.

Authors:  J O Hörnquist
Journal:  Scand J Soc Med       Date:  1990

3.  Loneliness correlates in advanced alcohol abusers. I. Social factors and needs.

Authors:  I Akerlind; J O Hörnquist; B Hansson
Journal:  Scand J Soc Med       Date:  1987

4.  Formal education level as a significant marker of clinical status in rheumatoid arthritis.

Authors:  L F Callahan; T Pincus
Journal:  Arthritis Rheum       Date:  1988-11

5.  Measuring functional ability in chronic arthritis: a critical review.

Authors:  M H Liang; A M Jette
Journal:  Arthritis Rheum       Date:  1981-01

6.  A prospective longitudinal study of abusers of alcohol granted disability pension.

Authors:  J O Hörnquist; M Elton
Journal:  Scand J Soc Med       Date:  1983

Review 7.  Quality of life--a review of the literature.

Authors:  M Fowlie; J Berkeley
Journal:  Fam Pract       Date:  1987-09       Impact factor: 2.267

8.  Self-assessed quality of life and metabolic control in persons with insulin-dependent diabetes mellitus (IDDM).

Authors:  B R Hanestad; J O Hörnquist; G Albrektsen
Journal:  Scand J Soc Med       Date:  1991-03

9.  Severity of disease and quality of life: a comparison in patients with cancer and benign disease.

Authors:  J O Hörnquist; B Hansson; I Akerlind; J Larsson
Journal:  Qual Life Res       Date:  1992-04       Impact factor: 4.147

10.  Measuring health in rheumatic disorders by means of a Swedish version of the sickness impact profile. Results from a population study.

Authors:  M Sullivan; M Ahlmén; B Archenholtz; G Svensson
Journal:  Scand J Rheumatol       Date:  1986       Impact factor: 3.641

View more
  10 in total

1.  Quality of life in Indian patients with rheumatoid arthritis.

Authors:  Gurdesh S Bedi; Nikhil Gupta; Rohini Handa; Hemraj Pal; R M Pandey
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

2.  Self-reported quality of life for patients with progressive neurological diseases.

Authors:  A Nordeson; B Engström; A Norberg
Journal:  Qual Life Res       Date:  1998-04       Impact factor: 4.147

Review 3.  Assessment of quality of life in rheumatoid arthritis: methods and implications.

Authors:  P Bendtsen; I Akerlind; J O Hörnquist
Journal:  Pharmacoeconomics       Date:  1994-04       Impact factor: 4.981

4.  Treatment perspectives in rheumatoid arthritis: a descriptive study in a Swedish healthcare district.

Authors:  P Bendtsen; P Bjurulf; E Trell; F Lindström; J E Larsson
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981

Review 5.  Type II diabetes and quality of life: a review of the literature.

Authors:  J O Hörnquist; A Wikby; U Stenström; P O Andersson; I Akerlind
Journal:  Pharmacoeconomics       Date:  1995       Impact factor: 4.981

6.  Determinants of health-related quality of life after temporal lobe epilepsy surgery.

Authors:  K J Rose; P A Derry; S Wiebe; R S McLachian
Journal:  Qual Life Res       Date:  1996-06       Impact factor: 4.147

7.  Quality of life: status and change (QLsc) reliability, validity and sensitivity of a generic assessment approach tailored for diabetes.

Authors:  J O Hörnquist; A Wikby; B Hansson; P O Andersson
Journal:  Qual Life Res       Date:  1993-08       Impact factor: 4.147

Review 8.  Pharmacological intervention in older patients with rheumatoid arthritis. Quality of life aspects.

Authors:  P Bendtsen; I Akerlind; J O Hörnquist
Journal:  Drugs Aging       Date:  1995-11       Impact factor: 3.923

Review 9.  Sociodemographic differences in quality of life in rheumatoid arthritis.

Authors:  Erik J Groessl; Theodore G Ganiats; Andrew J Sarkin
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

10.  Assessing Depression among Older Persons with Arthritis: A Nationwide Health Status Survey.

Authors:  Rajesh Nayak; Jigar Rajpura
Journal:  ISRN Rheumatol       Date:  2013-07-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.